Thompson Travis Alvin

Chief Financial Officer | Chief Accounting Officer | Chief Accounting Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

91.7%

Avg 3M Return

+17.1%

Avg 12M Return

+43.5%

Thompson Travis Alvin is a Chief Financial Officer at Bicycle Therapeutics plc. Recent SEC Form 4 filings include 0 buys and 22 sells.

Estimated insider holdings value: $261K based on current market prices.

Holdings by Company

BCYCApr 6, 2026

Current Shares65.4K

Value$261.5K

Net Activity-16,305

Bought: 0Sold: 16.3K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 6, 2026	BCYC Bicycle Therapeutics Plc	Chief Financial Officer	Sell	901	$4.93	$4,438.19	-0.7%	-	-
Jan 5, 2026	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	2,432	$6.64	$16,147.35	-1.8%	-26.0%	-
Oct 3, 2025	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	324	$8.40	$2,722.63	-0.5%	-20.2%	-
Jul 3, 2025	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	306	$7.20	$2,204.54	-0.5%	+12.1%	-
Apr 3, 2025	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	319	$7.84	$2,499.52	-0.5%	+0.1%	-32.0%
Jan 6, 2025	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	4,595	$14.64	$67,292.75	-4.3%	-54.6%	-55.8%
Nov 11, 2024	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sale+OE	6,256	$25.11	$157,113.55	-4.7%	-51.3%	-71.9%
Oct 3, 2024	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	153	$22.26	$3,405.78	-0.7%	-35.3%	-62.3%
Jul 3, 2024	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	148	$19.64	$2,906.72	-0.6%	+16.0%	-62.1%
Apr 3, 2024	BCYC Bicycle Therapeutics Plc	Chief Accounting Officer	Sell	152	$23.81	$3,619.12	-0.7%	-15.1%	-68.1%